Key Takeaways Sanofi will pay $2.2 billion for Dynavax Techologies as it looks to add another Hepatitis B and new shingles vaccines to its portfolio.The deal will pay Dynavax investors $15.50 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback